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ABSTRACT
Objectives: Equity in physical health of patients with
severe mental disorders is a major public health
concern. The aim of this cohort study was to examine
equity in access to coronary care among persons with
a history of severe mental disorder in 1998e2009.
Design: Nationwide register linkage cohort study.
Setting: Hospital care in the Finnish healthcare
system.
Population: The study population consisted of all
residents in Finland aged 40 years or older. All hospital
discharges in 1998e2009 with a diagnosis of coronary
heart disease or severe mental disorder were obtained
from the Care Register.
Primary outcome measures: Data on deaths,
hospitalisations and coronary revascularisations were
linked to the data set using unique personal identifiers.
Results: Patients with severe mental disorders had
increased likelihood of hospital care due to coronary
heart disease (RR between 1.22, 95% CI 1.18 to 1.25
and 1.93, 1.84 to 2.03 in different age groups) and in
40e49-year-olds also increased likelihood of
revascularisation (1.26, 1.16 to 1.38) compared with
persons without mental disorders. Access to
revascularisation was poorer among older persons
with severe mental disorders in relation to need
suggested by increased coronary mortality. In spite of
excess coronary mortality (ranging from 0.95, 0.89 to
1.01 to 3.16, 2.82 to 3.54), worst off were people with
a history of psychosis, who did not have increased use
of hospital care and had lower likelihood of receiving
revascularisations (ranging from 0.44, 0.37 to 0.51 to
0.74, 0.59 to 0.93) compared with persons without
mental disorders.
Conclusions: Selective mechanisms seem to be at
work in access to care and revascularisations among
people with severe mental disorders. Healthcare
professionals need to be aware of the need for targeted
measures to address challenges in provision of
somatic care among people with severe mental health
problems, especially among people with psychoses
and old people.
INTRODUCTION
Equity in health and equal access to health-
care according to need among vulnerable
groups, such as people with severe mental
disorders, is an indicator of well-functioning
health systems. Nevertheless, increased
morbidity and mortality due to somatic
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ARTICLE SUMMARY
Article focus
- Equity in physical health of patients with severe
mental disorders is a major public health concern
since increased morbidity and mortality due to
somatic disorders has repeatedly been reported
among them.
- The aim of this cohort study was to examine
equity in access to coronary care among persons
with a history of severe mental disorder in
Finland in 1998e2009.
Key messages
- Our results show poor access to coronary
revascularisation according to need among
people with severe mental disorders and espe-
cially poor access to hospital care and revascu-
larisations among people with psychotic
disorders.
- Healthcare professionals need to be aware of the
need for targeted measures to address chal-
lenges in provision of somatic care among
people with severe mental health problems,
especially among people with psychoses and
old people.
Strengths and limitations of this study
- We used nationwide, unselective representative
data concerning the total population of Finnish
residents in 1998e2009 collected from admin-
istrative registers with full coverage and based
on clinical diagnoses, which allowed us to put the
outcomes in proportion to the population at risk.
- We were able to examine the three major
diagnostic groups of severe mental disorders,
namely mood disorders, psychotic disorders and
substance abuse disorders.
- Our data do not enable us to evaluate whether
the poor access to care according to need among
people with severe mental disorders is due to
delay or avoidance in seeking care or poorer
responsiveness of the healthcare system to
somatic health problems of these vulnerable
patient groups.
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disorders, including cardiovascular disease, respiratory
disease and cancer, has repeatedly been reported in
persons with severe mental disorders compared with the
total population.1e8 These findings may derive both
from increased incidence and higher case death among
patients with mental disorders.9 10 Unhealthier lifestyles,
poorer socioeconomic circumstances, adverse metabolic
effects of antipsychotic medications and social conse-
quences of mental illness such as social isolation are
likely to explain part of the excess mortality. Another
important factor likely to contribute to these differences
is poorer access to and quality of healthcare.11 12
Accordingly, earlier studies have found elevated coro-
nary heart disease (CHD) mortality but reported no or
only slightly elevated use of hospital in- or outpatient
care compared with other coronary patients.9 13 Studies
have further reported that persons with a history of
psychoactive substance use disorders, psychosis or
mood disorders are less likely to receive b blockers,
aspirin, ACE inhibitors and statins compared with other
coronary patients,14e18 to be less likely to have had
a recent check-up of their cholesterol or blood pressure
level15 19 and to undergo revascularisation operations
less often.9 13 14 20 Similar results concerning coronary
revascularisations have been reported even after
controlling for cardiac risk factors and admission char-
acteristics.21 The study results suggest that access to
coronary care is not realised in proportion to need
among persons with a history of psychiatric disorders.
The studies have mainly been conducted in the USA and
many of them have been based on small or regional
samples or clinical samples of CHD patients. This study
contributes with a nationwide analysis of access to coro-
nary care and mortality, covering the total population,
providing an opportunity to study and compare
outcomes in all major diagnostic groups of severe mental
disorders, including substance use disorders. The
Finnish healthcare system is a good case for examining
coronary care in a universal healthcare state since the
Finnish system is funded mainly by tax revenues and
based on universal access to care according to clinical
need for all residents.22
The aim of this study was to provide a comprehensive
analysis of equity in access to coronary care among
people with a history of severe mental disorder. We
examined coronary mortality, risk of hospitalisation and
revascularisation procedures during the last decade
(1998e2009). Three groups of patients with severe
mental disorders were examined, that is, patients with
psychoactive substance use disorders, psychotic disorders
and mood disorders, and compared with population
without hospitalisations due to psychiatric diagnoses. We
further analysed the effects of sex and age to these
differences.
METHODS
This nationwide register-based study examines the access
to coronary care in 1998e2009. The study population
consists of all men and women resident in Finland and
older than 40 years at the beginning of each calendar
year. All hospital discharges in 1998e2009 containing
a diagnosis for CHD (ICD-10: I20-I25, I46.1, I46.9) or
severe mental disorder (ICD-10: F10-F39) were obtained
from the Finnish Care Register. The Care Register is
maintained by the National Institute for Health and
Welfare and includes data for all hospital inpatient care
in Finland, both public and private. The register
includes the dates for the beginning and end of each
inpatient care episode, the main diagnosis for the
episode (ICD-10) and two side diagnoses, as well as all
surgical procedures.
The cohort with severe mental disorders was defined
as those having a hospital care episode at least once with
main diagnosis for a psychotic disorder (ICD-10 F20-
F29), mood disorder (ICD-10 F30-F39) or substance use
disorder (ICD-10 F10-F19) at any time during 1 January
1998 to 31 December 2009. If an individual had been
hospitalised more than once and given more than one
main diagnosis, we hierarchically allocated the indi-
vidual to the psychosis subpopulation if diagnosed with
psychosis at least once. Patients with main substance use
related disorders and mood disorder diagnoses were
allocated to the substance use group. These persons
remained in the population with mental disorders
throughout the study period because of the long natural
course of the mental disorders in question. CHD
hospitalisations and coronary revascularisations among
them were compared with those of the total population
without severe mental disorders. The psychiatric popu-
lation at risk was defined as the annual mean population
of the severe mental disorder cohort in each year in
1998e2009. Stratification by year, 10-year age band, sex
and patient group was used. Annual mean population
figures for the whole Finnish population in 1998e2009
were obtained from Statistics Finland from which
numbers of people with severe mental disorders were
subtracted to achieve the population at risk for the non-
psychiatric population. Both were followed up from 1
January 1998 or the subsequent year following their 40th
birthday until the end of the study period in 31
December 2009 or death. The age of the persons with
and without mental disorders was updated in the end of
each year.
The psychiatric population comprises some 1.4 million
person-years including 579 478 for substance abuse
disorders, 399 909 for psychotic disorders and 440 752
for mood disorders, whereas the non-psychiatric
population comprise some 27.5 million person-years
over the study period. Data on coronary revascularisation
were individually extracted from the register. Data
on mortality were obtained from the cause of death
statistics.23 These individual-level data sets were linked
using unique personal identifiers.
The Finnish registers have been found to be a valid
and reliable tool for epidemiological research.24e26 The
Finnish Care Register has shown good validity with
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regard to psychotic disorders in general27 and even
in regard to a range of specific main mental health
diagnoses, such as bipolar disorder,28 and alcohol use
disorders.29
Main outcomes were RR of at least one hospitalisation
for CHD, first coronary revascularisations (coronary
artery bypass grafting or coronary angioplasty) and CHD
mortality. Incidence rates and their 95% CIs were
calculated for each patient group by sex and age.
Poisson regression models were used to study differ-
ences between the patient groups in access to coronary
care. The three outcome measures in relation to person-
years were examined by patient sex, calendar year, age
group, diagnostic group and the interaction between the
last two. As interactions between the diagnostic groups
and age groups were found, the RRs were calculated to
assess differences between diagnostic groups in each age
group. For the total risk ratios, the analyses were
performed controlling for patient sex, calendar year, age
group and diagnostic group. The analyses were
performed using SAS V.9.2.
The need for revascularisation operations was assessed
using two proxies. We compared likelihood of revascu-
larisation against age-specific coronary mortality and risk
of coronary hospitalisations in the three groups of
persons with severe mental disorders against persons
without these disorders. Ten-year age categories were
used in plotting the death rates and risks of hospital-
isation against the operation rates. The study protocol has
been approved by the Research Ethics Committee of the
National Centre for Health and Welfare (x163/2010).
RESULTS
There were 164 999 people with severe mental disorders
in the data during the study period of whom 67 659 were
classified as having a psychosis, 47 205 as having
a substance use-related disorder and 50 135 as having
a mood disorder. Those having psychotic disorders had
4991 coronary hospitalisations and underwent 568
revascularisations, those having substance abuse disor-
ders had 8178 hospitalisations and 1823 revascularisa-
tions and those with mood disorders had 9629
hospitalisations and 1327 revascularisations. Persons
without severe mental disorders had 370 452 coronary
hospitalisations and underwent 91 996 revascularisations
during the study period. Table 1 presents rates for
hospitalisation and revascularisation per 100 000 for
each group of people with severe mental disorder by age
and sex. Both hospitalisations and revascularisations
were more common among men in each age group but
the associations by different diagnostic groups were
similar for men and women. Persons with psychotic
disorder had lower rates for both hospitalisation and
revascularisation compared with other groups with
severe mental disorders, whereas the rates were higher
among persons with substance use disorders and mood
disorders compared with coronary people without
mental disorders.
CHD mortality was higher among persons with severe
mental disorders compared with people without
a history of a severe mental disorder (table 2). The
differences in mortality risk were especially marked
among persons with disorders due to psychoactive
substance use and psychotic disorders, and a pattern of
decreasing excess risk was found by age: the younger the
age group, the larger the excess mortality risk.
Overall, people with severe mental disorders had an
increased risk of being hospitalised due to CHD compared
with patients without mental disorders (table 3). This was
especially true for younger (40e49 years old) persons with
substance use disorders or mood disorders, among whom
the likelihood of hospitalisation was more than double
compared with those without mental disorders. A statisti-
cally significant age pattern was detected among these two
patient groups: the younger the age group, the larger the
excess likelihood of hospitalisation. In persons with
a psychosis diagnosis, however, the likelihood was similar
to those without mental disorders and no age gradient was
detected.
The sex-specific analyses revealed that differences were
more pronounced among women with disorders due to
psychoactive substance use and mood disorders (data
not shown).
The likelihood of coronary revascularisations (table 4)
was higher among 40e49-year-old persons with disorders
due to psychoactive substance use and 40e59-year-old
persons with mood disorders. In older age groups
among these patient groups and among persons with
psychosis, the likelihood of revascularisation was smaller
compared with persons without mental disorders. The
likelihood of revascularisation was especially low among
older (60+ years) persons with psychotic disorders
among whom the RR was approximately half of that
among persons without mental disorders. We further
analysed whether the results differ by type of first revas-
cularisation (bypass operation, angioplasty). Since the
results were similar for both types of revascularisation,
numerical results are not presented.
Age-specific revascularisation rates are plotted against
age-specific coronary mortality rates and hospitalisation
rates in figure 1. Among persons with substance use
disorders, revascularisation rates were below those
found among persons without mental disorders at each
level of mortality except for the two oldest age groups
(figure 1A). Among persons with mood disorders,
revascularisation rates exceeded than those found
among persons without mental disorders in the youngest
age group but were lower in older age groups at each
level of mortality. Among persons with psychotic disor-
ders, revascularisation rates were below than those found
in other groups at each level of coronary mortality. When
coronary hospitalisation was used as a proxy for need
(figure 1B), the curves were similar among persons with
substance use disorders and mood disorders: at each
level of hospitalisation, the revascularisation rates were
lower than those among persons without mental
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disorders except for the oldest age group. The rates were
especially low among persons with psychotic disorders.
DISCUSSION
This nationwide register-based study examined equity in
coronary care among the three major groups of people
with severe mental disorders in 1998e2009 in Finland
compared with people without these disorders. Three
main outcomes were examined, namely coronary
mortality, coronary hospitalisation and first coronary
revascularisations. Persons with substance use disorders
or mood disorders had increased likelihood of hospital
care due to CHD but not persons with psychosis. The
same pattern was seen for coronary revascularisations
among young age groups. Increased hospitalisations and
revascularisations are likely to reflect the increased
prevalence of CHD among people with severe mental
disorders as suggested by increased coronary mortality
reported in earlier studies.1e8 However, access to revas-
cularisation was poorer among older persons in these
patient groups in relation to need suggested by
increased CHD mortality indicating that selective
mechanisms may differ across age groups. Whereas
earlier research has shown increased CHD incidence
and mortality among persons with psychotic disorders,5
corroborated by our results of increased coronary
mortality, persons with psychosis had no differences in
the likelihood of hospital care to persons without severe
mental disorders. We further found selective under-
representation of people with psychotic disorders among
those receiving revascularisation interventions in all age
groups. While older persons with substance use disor-
ders and mood disorders had poorer access to revascu-
larisation compared with those without severe mental
disorders, the risk ratios were especially low among
persons with psychotic disorders. Selective mechanisms
seem to be at work at two levels in this patient group.
First, these patients seem to have poorer access to
hospital care as compared with people with mood or
substance abuse-related disorders and second, poorer
access to revascularisation.
The strength of our study was that we used nationwide,
unselective representative data concerning the total
population of Finnish residents in 1998e2009 collected
from administrative registers with full coverage and
based on clinical diagnoses. We were also able to include
persons with substance use disorders. The accuracy and
coverage of the Finnish Care Register has, in general,
been reported to be good,23 and the accuracy of CHD
data in the register has proved to be good.25 A weakness
of our study is that persons with less severe mental
disorders, who have not been hospitalised, are excluded
from the population with severe mental disorders and
can therefore appear in the population without severe
mental disorders. Thus, our results are representative
only for the population with mental disorders severe
enough to require hospitalisation and rather underesti-
mate the differences. Another weakness of our study is
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that we could not control for possible comorbidities or
health behaviours that could have an effect on the
differences.
Our results concerning coronary mortality, hospital-
isations and revascularisation procedures are in line with
those reported from studies examining total populations
of persons with specific severe mental disorders1 9 13 14
and our results replicate especially the low hospital
admission rates and revascularisation rates among
persons with psychosis in relation to need indicated by
excess coronary mortality.16 Some studies have reported
no differences in hospitalisations or revascularisations,
but these studies have been based on clinical coronary
populations and not total populations of persons with
severe mental disorders,30e32 whereas our study covered
the total population of persons with mental disorders
severe enough to require hospitalisation. Our study
design allowed us to put the outcomes in proportion to
the population at risk. Our study further adds to the
literature by examining the outcomes by age. Our results
suggest that both access to and quality of care as well as
outcomes may differ by age among persons with severe
mental disorders. Additionally, studies including
substance use disorders are rare.13 33 Kisely and
colleagues33 reported similar likelihood of coronary
procedures among persons with substance use disorders
compared with the total population from Nova Scotia,
Canada. Lawrence and colleagues13 reported similar
admission rates, and among men similar revascularisa-
tion rates, among persons with substance use problems
compared with the general population in Western
Australia.
The register data used in our study do not enable us to
evaluate whether the poor access to coronary revascu-
larisation according to need found in our study among
people with severe mental disorders and especially poor
access to hospital care and revascularisations among
people with psychotic disorders are due to delay or
avoidance in seeking care or poorer responsiveness of
the healthcare system to somatic health problems of
these vulnerable patient groups. Both may be related to
stigma associated with mental health disorders and
especially with psychosis.34 Another possible explanation
that can play a role in differences in revascularisation
rates are ethical and consent issues as well as contrain-
dications for invasive surgical procedures due to
comorbid conditions or treatments. The age gradient in
access to CHD treatment points towards a role of stigma,
as stigmatising attitudes towards mental disorders are
more common among older people in Finland.35 The
lack of access to coronary treatment is likely to reflect
shortcomings in provision of health services and in
care seeking because of stigma associated to mental
disorders in healthcare and self-stigma among people
with mental disorders interact. Those already labelled by
the health services may decide to distance themselves
from the label, forgoing treatment or becoming non-
compliant.36 Our results are in line with the high level of
discrimination experienced especially by people with
schizophrenia.37
Our results suggest that even in a highly developed
welfare state with an egalitarian public health system
with full population coverage, intentional or uninten-
tional structural discrimination of people with severe
mental disorders, especially people with psychotic
disorders, occurs. The healthcare professionals need to
be aware of possible stigmatising attitudes among them
and of the need for targeted measures to address the
needs for somatic healthcare among people with severe
mental health problems and especially among people
with psychosis. Addressing stigma is a core component in
aspirations to reduce excess cardiovascular mortality
among people with severe mental disorders.
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